IMVT
Immunovant, Inc. · Healthcare
CEO Peter Salzmann sold $532K of Immunovant, Inc.
Sold$531,581
$32.78Price
16,217Shares
−2%Stake
What IMVT did after the filing
- The stock from Fri, Nov 24 close, $33.42
- +31.0%
- S&P 500, same days
- +4.5%
Measured over 30 trading days, to the Jan 9 close.
Traded Wed, Nov 22. Filed Fri, Nov 24, 9:55 AM ET, during the session. Returns use the Nov 24 close and the Jan 9 close. Not investment advice.